Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
6,784 total articles
Outlook Therapeutics, a biopharmaceutical company focused on treatments for retina diseases, announced the closing of a $5 million registered direct offering priced at-the-market to raise capital. Concurrently, the company issued unregistered warrants potentially raising an additional $5 million if exercised. The net proceeds will be used primarily…
Definitive Healthcare Corp., a leading healthcare market data and analytics company, announced it will release its first quarter 2026 financial results on May 7, 2026, after market close. A conference call and webcast will be held to discuss the results with investors and analysts.
Dyne Therapeutics announced inducement equity awards to 18 new employees as incentives for joining the company. The awards include stock options and restricted stock units vesting over four years, in compliance with Nasdaq Listing Rule 5635(c)(4). This move aims to attract talent to support development programs targeting genetically driven neuromus…
ABM Industries (NYSE: ABM) has been honored with an Edison Award in Commercial Technology for its ABM Connect platform, which integrates AI, IoT, and data intelligence to revolutionize facility operations by providing real-time visibility and predictive insights. This recognition validates ABM's innovative approach to transforming facility manageme…
Dynagas LNG Partners LP announced a quarterly cash distribution of $0.5625 per unit for its Series A Cumulative Redeemable Perpetual Preferred Units, payable on May 12, 2026. This marks the forty-third consecutive distribution since the Series A units began trading on the NYSE, underscoring the company's consistent cash flow from its LNG carrier op…
SoundThinking, Inc., a Nasdaq-listed public safety technology firm, announced it will release its financial results for Q1 2026 after market close on May 14, 2026, followed by a conference call to discuss the results and outlook. The company continues to provide AI-driven public safety solutions to over 300 customers and around 2,100 agencies.
Nature's Sunshine Products, Inc., a global manufacturer and marketer of herbal and nutritional supplements, will report its first quarter 2026 financial results on May 7, 2026, followed by a conference call hosted by CEO Kenneth Romanzi and CFO Shane Jones to discuss the results and answer investor questions.
Quest Resource Holding Corporation, a leader in environmental waste and recycling services, will report its financial results for Q1 2026 after market close on May 7, 2026, followed by a management conference call reviewing the results and business outlook.
Baker Hughes declared a quarterly cash dividend of $0.23 per share payable on May 15, 2026, to shareholders of record as of May 5, 2026. The company plans to fund the dividend from cash generated by operations. Baker Hughes is a global energy technology company operating in over 120 countries, focusing on safer, cleaner, and more efficient energy s…
Silvaco Group, Inc., a semiconductor design software company, announced it will release its financial results for the first quarter ended March 31, 2026, after market close on May 7, 2026. The company will host a conference call to discuss the results and outlook for Q2 2026.
Kiniksa Pharmaceuticals International announced it will report its first quarter 2026 financial results on April 28, 2026, via a conference call and webcast. The company will also discuss recent portfolio execution. The event will be accessible through the company's website, with a replay available shortly after.
ESH Acquisition Corp. disclosed that it has received a Nasdaq deficiency notice due to the failure to file its Form 10-K for fiscal 2025. The company will cease operations by April 30, 2026, redeem all public shares, and proceed with dissolution as it will not complete an initial business combination by the extended deadline. Trading of public shar…
Tectonic Therapeutic, a clinical-stage biotech company specializing in therapeutic proteins targeting GPCRs, appoints Jessica Chutter, a seasoned healthcare investment banking expert, to its Board of Directors. This move is aimed at leveraging her strategic and capital markets expertise to support Tectonic's growth and transition into a multi-produ…
TTM Technologies, a leading global manufacturer of technology products such as RF components and printed circuit boards, announced its 2026 Investor Day to be held on May 27, 2026, at the Nasdaq Exchange in New York City. The event will feature presentations and Q&A with executive leadership and will be webcast live.
WW International, Inc., the leader in science-backed weight management, announced it will release its first quarter 2026 earnings before market open on May 7, 2026, followed by a conference call to discuss results. The company continues to emphasize its integrated, personalized weight management approach, including support for GLP-1 medications and…
Waterstone Financial, Inc. announced its Q1 2026 results, reporting net income of $6.0 million ($0.34 per diluted share), doubling from $3.0 million in Q1 2025. Growth was driven by expanded net interest margins, increased loan originations in its mortgage segment, and strong community banking performance. The company increased its quarterly divide…
IREN Limited, a vertically integrated AI cloud provider specializing in data centers and GPU clusters powered by renewable energy, will release its Q3 FY26 financial results on May 7, 2026, followed by a conference call with live Q&A for investors and analysts.
Regeneron Pharmaceuticals has reached an agreement with the U.S. government to reduce drug costs by aligning Medicaid and future medicine prices with those of other developed countries. As part of this agreement, Regeneron will provide its new gene therapy, Otarmeni™, free of charge in the U.S., and make cardiovascular drug Praluent® available for …
Magnera Corporation (NYSE: MAGN), a global materials solutions company, will release its Q2 2026 earnings before NYSE trading on May 7, 2026, followed by a detailed investor presentation and conference call. The company serves diverse sectors including hygiene, protective apparel, construction, and food & beverage industries across 45 facilities wo…
Teck Resources Limited announced a quarterly dividend of $0.125 per share payable on June 30, 2026, demonstrating the company's ongoing commitment to shareholder returns amid its focus on responsible growth in the mining sector. The dividend applies to both Class A common shares and Class B subordinate voting shares.
VivoPower PLC has launched a formal competitive bidding process to select tenants for its recently acquired 41.5MW data center in Mo i Rana, Norway. The facility, powered by low-cost renewable hydroelectric energy, is attracting strong interest from AI neocloud operators and hyperscalers. The lease selection aims to optimize commercial terms, opera…
Progyny, Inc., a leading women's health and family building solutions company, announced it will report its Q1 2026 financial results after market close on May 7, 2026, followed by a conference call. The press release details access information for investors and media, highlighting the company's market recognition and commitment to innovative healt…
Grace Therapeutics announced that the FDA has issued a Complete Response Letter regarding the New Drug Application for GTx-104, a novel injectable nimodipine formulation for aneurysmal subarachnoid hemorrhage (aSAH). The FDA cited issues related to chemistry, manufacturing controls, and non-clinical information but did not request more clinical dat…
Regeneron Pharmaceuticals, Inc. announced FDA accelerated approval of Otarmeni (lunsotogene parvec-cwha), the first and only gene therapy for severe-to-profound genetic hearing loss caused by OTOF gene variants. Based on the pivotal CHORD trial showing 80% of participants met the primary endpoint with significant hearing improvements, Otarmeni repr…
C&F Financial Corporation reported net income of $6.8 million for Q1 2026, up from $5.4 million in Q1 2025, driven by growth in the community banking and mortgage banking segments despite challenges in consumer finance. Results were supported by strong loan and deposit growth, a higher net interest margin, and a 58% increase in mortgage origination…
